AMNEAL PHARMACEUTICALS, INC. Grants Receivable
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Grants Receivable of INR 10.00 billion as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Nontrade Receivables
us-gaap:GrantsReceivable · last filed 2022-05-06
- 2021-12-31: Grants Receivable 10.00B INR.
- 2021-11-30: Grants Receivable 10.00B INR.
INR
| Period end | Grants Receivable |
|---|---|
| 2021-12-31 | 10.00B INR 10-K · filed 2022-03-01 |
| 2021-11-30 | 10.00B INR 10-Q · filed 2022-05-06 |
USD
| Period end | Grants Receivable | Grants Receivable as first filed |
|---|---|---|
| 2021-11-30 | $132.30M 10-Q · filed 2022-05-06 | $134.00M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |